The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Immune Dysfunction and Risk of Infection in Chronic Kidney Disease
Abstract
Cardiovascular disease and infections are directly or indirectly associated with an altered immune response, which leads to a high incidence of morbidity and mortality, and together, they account for up to 70% of all deaths among patients with chronic kidney dysfunction. Impairment of the normal reaction of the innate and adaptive immune systems in chronic kidney disease predisposes patients to an increased risk of infections, virus-associated cancers, and a diminished vaccine response. On the other hand, an abnormal, exaggerated reaction of the immune systems can also occur in this group of patients, resulting in increased production and decreased clearance of proinflammatory cytokines, which can lead to inflammation and its sequelae (eg, atherosclerotic cardiovascular disease). Epigenetically, modifications in hematopoietic stem cells involving a shift from lymphoid to myeloid cell lineage may underlie uremia-associated immunological senescence, which is not reversed by renal replacement therapy, including kidney transplantation. Measures aimed at attenuating the immune abnormalities in chronic kidney disease/end-stage renal disease should be an area of focused research as this could potentially lead to a better understanding and, thus, development of therapies that could reduce the disastrously high death rate in this patient population. The aim of the present article is to review the characteristics, causes, and mechanisms of the immune dysfunction related to chronic kidney disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Oxidized LDL Modulates Apoptosis of Regulatory T Cells in Patients with ESRD
Meier, P., Golshayan, D., Blanc, E., Pascual, M. A., & Burnier, M. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008070734 · Cited by 51
RetractedGut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
The gut microbiota shapes intestinal immune responses during health and disease
Round, J. L., & Mazmanian, S. K. (2009) · Nature Reviews Immunology · doi:10.1038/nri2515 · Cited by 5,029
Gut microbiota in health and disease
Sekirov, I., Russell, S. L., Antunes, L. C. M., & Finlay, B. B. (2010) · Physiological Reviews · doi:10.1152/physrev.00045.2009 · Cited by 4,182
Interactions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173
Diet, gut microbiota and immune responses
Maslowski, K. M., & Mackay, C. R. (2011) · Nature Immunology · doi:10.1038/ni0111-5 · Cited by 1,261
Aspects of Immune Dysfunction in End-stage Renal Disease
Kato, S., Chmielewski, M., Honda, H., Pecoits-Filho, R., Matsuo, S., Yuzawa, Y., Tranaeus, A., Stenvinkel, P., & Lindholm, B. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00950208 · Cited by 1,087
Stenvinkel, P., Ketteler, M., Johnson, R. J., Lindholm, B., Pecoits-Filho, R., Riella, M., Heimbürger, O., Cederholm, T., & Girndt, M. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00200.x · Cited by 932
Witko-Sarsat, V., Friedlander, M., Khoa, T. N., Capeillère-Blandin, C., Nguyen, A. T., Canteloup, S., Dayer, J.-M., Jungers, P., Drüeke, T., & Descamps-Latscha, B. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2524 · Cited by 878
Sarnak, M. J. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00337.x · Cited by 723
Stearns-Kurosawa, D. J., Osuchowski, M. F., Valentine, C., Kurosawa, S., & Remick, D. G. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130327 · Cited by 549
The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease
Anders, H.-J., Andersen, K., & Stecher, B. (2013) · Kidney International · doi:10.1038/ki.2012.440 · Cited by 493
Septicemia in dialysis patients: Incidence, risk factors, and prognosis
Powe, N. R., Jaar, B., Furth, S. L., Hermann, J., & Briggs, W. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.0550031081.x · Cited by 477
McIntyre, C. W., Harrison, L. E. A., Eldehni, M. T., Jefferies, H. J., Szeto, C.-C., John, S. G., Sigrist, M. K., Burton, J. O., Hothi, D., Korsheed, S., et al. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04610510 · Cited by 460
Meyer, T. W., & Hostetter, T. H. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071313 · Cited by 458
Toll-like receptors: Activation, signalling and transcriptional modulation
De Nardo, D. (2015) · Cytokine · doi:10.1016/j.cyto.2015.02.025 · Cited by 457
Pathobionts of the gastrointestinal microbiota and inflammatory disease
Chow, J., Tang, H., & Mazmanian, S. K. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.07.010 · Cited by 448
Associations between circulating inflammatory markers and residual renal function in CRF patients
Pecoits-Filho, R., Heimbürger, O., Bárány, P., Suliman, M., Fehrman-Ekholm, I., Lindholm, B., & Stenvinkel, P. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00353-6 · Cited by 448
Proinflammatory actions of angiotensins
Ruiz-Ortega, M., Lorenzo, O., Suzuki, Y., Rupérez, M., & Egido, J. (2001) · Current Opinion in Nephrology and Hypertension · doi:10.1097/00041552-200105000-00005 · Cited by 412
Oxidative Stress Is Progressively Enhanced With Advancing Stages of CKD
Dounousi, E., Papavasiliou, E., Makedou, A., Ioannou, K., Katopodis, K. P., Tselepis, A., Siamopoulos, K. C., & Tsakiris, D. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.08.015 · Cited by 410
Arici, M., & Walls, J. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.059002407.x · Cited by 398
Host Defenses and Immunologic Alterations Associated with Chronic Hemodialysis
GOLDBLUM, S. E., & REED, W. P. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-4-597 · Cited by 367
Oxidative stress in uremia: Nature, mechanisms, and potential consequences
Vaziri, N. D. (2004) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2004.06.026 · Cited by 355
Erythropoietin resistance: the role of inflammation and pro‐inflammatory cytokines
Macdougall, I. C., & Cooper, A. C. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.suppl_11.39 · Cited by 336
Basic Science and Dialysis: Disturbances of Acquired Immunity in Hemodialysis Patients
Eleftheriadis, T., Antoniadi, G., Liakopoulos, V., Kartsios, C., & Stefanidis, I. (2007) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2007.00283.x · Cited by 323
Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway
Nataraj, C., Oliverio, M. I., Mannon, R. B., Mannon, P. J., Audoly, L. P., Amuchastegui, C. S., Ruiz, P., Smithies, O., & Coffman, T. M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7451 · Cited by 308
Angiotensin actions in the kidney: Renewed insight into the old hormone
Ichikawa, I., & Harris, R. C. (1991) · Kidney International · doi:10.1038/ki.1991.249 · Cited by 284
Jurewicz, M., McDermott, D. H., Sechler, J. M., Tinckam, K., Takakura, A., Carpenter, C. B., Milford, E., & Abdi, R. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006070707 · Cited by 210
Premature aging of circulating T cells in patients with end-stage renal disease
Betjes, M. G. H., Langerak, A. W., van der Spek, A., de Wit, E. A., & Litjens, N. H. R. (2011) · Kidney International · doi:10.1038/ki.2011.110 · Cited by 207
Vasoactive hormones and renal sclerosis
Egido, J. (1996) · Kidney International · doi:10.1038/ki.1996.82 · Cited by 198
Naïve and central memory T-cell lymphopenia in end-stage renal disease
Yoon, J.-W., Gollapudi, S., Pahl, M. V., & Vaziri, N. D. (2006) · Kidney International · doi:10.1038/sj.ki.5001550 · Cited by 194
Oxidative stress and inflammation: Implications in uremia and hemodialysis
Libetta, C., Sepe, V., Esposito, P., Galli, F., & Dal Canton, A. (2011) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2011.06.988 · Cited by 175
Monocyte subpopulations and cardiovascular risk in chronic kidney disease
on behalf of the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association—European Dialysis and Transplant Association (ERA–EDTA), Heine, G. H., Ortiz, A., Massy, Z. A., Lindholm, B., Wiecek, A., Martínez-Castelao, A., Covic, A., Goldsmith, D., Süleymanlar, G., et al. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.41 · Cited by 165
Bekay, R. E., Álvarez, M., Monteseirín, J., Álba, G., Chacón, P., Vega, A. P., Martín‐Nieto, J., Jiménez, J., Pintado, E., Bedoya, F. J., et al. (2003) · Blood · doi:10.1182/blood-2002-09-2785 · Cited by 159
Litjens, N. H. R., van Druningen, C. J., & Betjes, M. G. H. (2005) · Clinical Immunology · doi:10.1016/j.clim.2005.09.007 · Cited by 151
Meier, P., Dayer, E., Blanc, E., & Wauters, J. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v131204 · Cited by 148
Anti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events
Girndt, M., Kaul, H., Sester, U., Ulrich, C., Sester, M., Georg, T., & Köhler, H. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00504.x · Cited by 135
The paradoxical effects of vitamin D on type 1 mediated immunity
Cantorna, M. T., Yu, S., & Bruce, D. (2008) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.04.004 · Cited by 132
Uremia causes premature ageing of the T cell compartment in end-stage renal disease patients
Meijers, R. W. J., Litjens, N. H. R., de Wit, E. A., Langerak, A. W., van der Spek, A., Baan, C. C., Weimar, W., & Betjes, M. G. H. (2012) · Immunity & Ageing · doi:10.1186/1742-4933-9-19 · Cited by 111
Patruta, S., & Hörl, W. H. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.055suppl.69125.x · Cited by 106
Gut Bacterial Translocation Contributes to Microinflammation in Experimental Uremia
Wang, F., Zhang, P., Jiang, H., & Cheng, S. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2242-0 · Cited by 105
Inflammation in End-Stage Renal Disease – A Fire that Burns within
Stenvinkel, P. (2005) · KARGER eBooks · doi:10.1159/000085525 · Cited by 102
High-dose parenteral iron sucrose depresses neutrophil intracellular killing capacity
Deicher, R., Ziai, F., Cohen, G., Müllner, M., & Hörl, W. H. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00125.x · Cited by 92
T cell activation defect in hemodialysis patients: Evidence for a role of the B7/CD28 pathway
Girndt, M., Köhler, H., Schiedhelm-Weick, E., Büschenfelde, K. M. Z., & Fleischer, B. (1993) · Kidney International · doi:10.1038/ki.1993.252 · Cited by 91
Oxidative stress in hemodialysis patients: Is NADPH oxidase complex the culprit?
Morena-Carrere, M., Cristol, J., Senécal, L., Leray‐Moragues, H., Krieter, D. H., & Canaud, B. (2002) · Kidney International · doi:10.1046/j.1523-1755.61.s80.20.x · Cited by 84
Ando, M., Shibuya, A., Tsuchiya, K., Akiba, T., & Nitta, K. (2006) · Kidney International · doi:10.1038/sj.ki.5001548 · Cited by 76
Relationship between Plasma Leptin Level and Chronic Kidney Disease
Shankar, A., Syamala, S., Xiao, J., & Muntner, P. (2012) · International Journal of Nephrology · doi:10.1155/2012/269532 · Cited by 76
Verkade, M. A., van de Wetering, J., Klepper, M., Vaessen, L. M. B., Weimar, W. W., & Betjes, M. G. H. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00781.x · Cited by 75
FGF23 in Chronic Kidney Disease
WAHL, P. W., & Wolf, M. S. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0887-1_8 · Cited by 74
Kidney transplantation and the ageing immune system
McKay, D. B., & Jameson, J. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.242 · Cited by 62
Chronic Kidney Disease and Premature Ageing of the Adaptive Immune Response
Betjes, M. G. H., & Litjens, N. H. R. (2014) · Current Urology Reports · doi:10.1007/s11934-014-0471-9 · Cited by 58
Hochdörfer, T., Kuhny, M., Zorn, C. N., Hendriks, R. W., Vanhaesebroeck, B., Bohnacker, T., Krystal, G., & Huber, M. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.01.012 · Cited by 54
Expression of Scavenger Receptor CD36 in Chronic Renal Failure Patients
Chmielewski, M. S., Bryl, E., Marzec, L., Aleksandrowicz, E., Witkowski, J. M., & Rutkowski, B. (2005) · Artificial Organs · doi:10.1111/j.1525-1594.2005.29097.x · Cited by 48
Uremia-associated immune defect: The IL-10–CRP axis
Girndt, M., Ulrich, C., Kaul, H., Sester, U., Sester, M., & Köhler, H. (2003) · Kidney International · doi:10.1046/j.1523-1755.63.s84.14.x · Cited by 48
Enhanced scavenger receptor expression in monocyte-macrophages in dialysis patients
Ando, M., Lundkvist, I., Bergström, J., & Lindholm, B. (1996) · Kidney International · doi:10.1038/ki.1996.107 · Cited by 48
Suzuki, Y., Gómez‐Guerrero, C., Shirato, I., López‐Franco, Ó., Hernández-Vargas, P., Sanjuán, G., Ruiz‐Ortega, M., Sugaya, T., Okumura, K., Tomino, Y., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4136 · Cited by 45
PROGRESS IN UREMIC TOXIN RESEARCH: Adiponectin in Patients with Chronic Kidney Disease
Adamczak, M., Chudek, J. T., & Więcek, A. (2009) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2009.00587.x · Cited by 43
Verapamil reverses abnormal [Ca2+]i and carbohydrate metabolism of PMNL of dialysis patients
Hörl, W. H., Haag–Weber, M., Mai, B., & Massry, S. G. (1995) · Kidney International · doi:10.1038/ki.1995.240 · Cited by 43
Kuroki, Y., Tsuchida, K., Go, I., Aoyama, M., Naganuma, T., Takemoto, Y., & Nakatani, T. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.19.5.783 · Cited by 43
Significant Elevations in Serum Mannose-Binding Lectin Levels in Patients with Chronic Renal Failure
Satomura, A., Endo, M., Ohi, H., et al. (2002) · The Nephron journals/Nephron journals · doi:10.1159/000064089 · Cited by 36
Potential risk for infection and atherosclerosis due to iron therapy
Sengoelge, G., Sunder–Plassmann, G., & Hörl, W. H. (2005) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2004.09.018 · Cited by 32
Erythropoietin enhances immunostimulatory properties of immature dendritic cells
Rocchetta, F., Solini, S., Mister, M., Mele, C., Cassis, P., Noris, M., Remuzzi, G., & Aiello, S. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2011.04417.x · Cited by 31
Ando, M., Gåfvels, M. E., Bergström, J. P., Lindholm, B., & Lundkvist, I. (1997) · Kidney International · doi:10.1038/ki.1997.110 · Cited by 31
Cited by
Antonelli, M., Penfold, R. S., Merino, J., Sudre, C. H., Molteni, E., Berry, S., Canas, L. S., Graham, M. S., Klaser, K., Modat, M., et al. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(21)00460-6 · Cited by 843
Rincon-Arevalo, H., Choi, M., Stefanski, A.-L., Halleck, F., Weber, U., Szelinski, F., Jahrsdörfer, B., Schrezenmeier, H., Ludwig, C., Sattler, A., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abj1031 · Cited by 273
Basile, C., Combe, C., Pizzarelli, F., Covic, A., Davenport, A., Kanbay, M., Kirmizis, D., Schneditz, D., van der Sande, F., & Mitra, S. (2020) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaa069 · Cited by 270
Metadata
- Authors
- Syed-Ahmed, M., & Narayanan, M.
- Venue
- Advances in Chronic Kidney Disease
- Publisher
- Elsevier BV
- Published
- 2019-01
- Volume
- 26
- Issue
- 1
- Pages
- 8-15
- ISSN
- 1548-5595 (ISSN-L)
- OpenAlex
- W2921513648
- Cited by
- 411
- References
- 63
- FWCI
- 27.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.